Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Dermatology
/ Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Complimentary
Categories:
Activity Type
,
ANCC
,
CME
,
Credit Type
,
Dermatology
,
Endocrinology
,
Family Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Pediatrics
,
Physician
,
Physician Assistant
,
Profession
Related products
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Read more
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more
Scroll To Top